GALILEO 4D - STUDY PURPOSE

 

The purpose of this project is to evaluate whether a rivaroxaban-based strategy, following successful TAVR, compared to an antiplatelet-based strategy, is superior in reducing subclinical valve leaflet thickening and motion abnormalities – as evaluated by 4DCT imaging at three months following TAVR.